FibroGen to Present at SVB Securities Global Biopharma Conference
February 02, 2023 07:00 ET
|
FibroGen, Inc.
SAN FRANCISCO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in a virtual fireside chat at the SVB...